Psychedelic compounds such as psilocybin, a substance found in various mushroom species, are garnering more research support as novel treatments for psychiatric disorders, but questions remain concerning who they may help the most.
Greenlane Q2 Revenue Declines to $19.6 Million
GREENLANE REPORTS Q2 2023 FISCAL RESULTS BOCA RATON, FL / August 14, 2023 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (NASDAQ:GNLN), a premier global